Healthcare Services (HCSG) is a Great Momentum Stock: Should You Buy?

Healthcare Services (HCSG) is identified as a strong momentum stock by Zacks, holding a Zacks Rank #1 (Strong Buy) and a Momentum Style Score of B. HCSG's shares have outperformed both its industry and the S&P 500, with a 57.07% monthly price change versus the industry's 6.55% and a 29.53% increase over the past year compared to the S&P 500's 13.25%; furthermore, earnings estimates have been revised upwards, increasing the full-year consensus from $0.80 to $0.84 in the last two months.

Analysis

Healthcare Services Group (HCSG) has demonstrated significant positive momentum, as highlighted by its Zacks Rank #1 (Strong Buy) and Momentum Style Score of B. The company's stock performance has substantially outpaced both its industry and the broader market. Specifically, HCSG shares appreciated 3.71% over the past week, compared to the Zacks Business - Services industry's 2.34% gain, and surged an impressive 57.07% over the past month, far exceeding the industry's 6.55% rise. Over a longer horizon, HCSG's shares have risen 41.71% in the past quarter and 29.53% in the last year, contrasting sharply with the S&P 500's movements of -2.63% and +13.25% respectively over the same periods. This robust price performance is supported by an average 20-day trading volume of 938,258 shares. Furthermore, the earnings outlook for HCSG is positive, with one upward earnings estimate revision for the full year over the past two months and no downward revisions, leading to an increase in the consensus estimate from $0.80 to $0.84. A similar trend of one upward revision and no downward revisions is noted for the next fiscal year. According to Zacks' research methodology, stocks with a #1 or #2 Rank and a Style Score of A or B tend to outperform the market in the subsequent one-month period, suggesting a favorable near-term outlook for HCSG based on these indicators.

Key Decisions for Investors

• Investors employing a momentum strategy may consider HCSG given its strong recent price performance, #1 Zacks Rank, and positive earnings estimate revisions.
• Monitor for continued strength in trading volume and further upward earnings estimate revisions to validate the sustainability of the current momentum.
• While the combination of a Zacks Rank #1 and a Momentum Score of B suggests potential near-term outperformance, investors should assess if the significant recent share price appreciation, particularly the 57.07% monthly gain, has already priced in near-term catalysts.